TERUMO CORP./ JP3546800008 /
| 01/09/2024 16:00:29 | Chg. 0.000 | Volume | Bid16:00:29 | Ask16:00:29 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.400EUR | 0.00% | - Turnover: - |
16.400Bid Size: - | 17.100Ask Size: - | 24.76 bill.EUR | - | - |
GlobeNewswire
12/08
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
30/07
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board o...
GlobeNewswire
10/07
Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
GlobeNewswire
10/06
Over 80 Organizations Kick Off Blood Advocacy Week by Urging Congress to Support the Blood Supply as...
GlobeNewswire
04/06
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire
13/05
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
30/04
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
30/04
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire
02/04
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
GlobeNewswire
26/03
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
13/03
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
06/03
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
26/02
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
20/02
TransPerfect’s GlobalLink/Adobe Experience Manager (AEM) Integration Adds 30+ Global Brands in 2023
GlobeNewswire
08/01
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
13/11/2023
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
19/09/2023
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for...
GlobeNewswire
03/02/2022
Applied Science, Inc. Announces New Vice President of Sales, Marketing & Customer Care, Ral Trujillo
